Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)

被引：0
|
作者：
Jung, Sung-Hoon [1 ]
Lee, Je-Jung [2 ]
Kim, Mihee [3 ]
Min, Chang-Ki [4 ]
Lee, Ji Yun [5 ]
Jo, Jae-Cheol [6 ]
Yoon, Sung-Soo [7 ]
Lim, Sung-Nam [8 ]
Do, Young Rok [9 ]
Kim, Kihyun [10 ]
Lee, Jae Hoon [11 ]
Yoo, Kwai Han [11 ]
Bae, Sung Hwa [12 ]
Yi, Jun Ho [13 ]
Jung, Jongheon [14 ]
Eom, Hyeon-Seok [15 ]
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Sch Med, Hwasun, South Korea
[2] Kyungpook Natl Univ, Dept Hematol Oncol, Sch Med, Kyungpook Natl Univ Hosp, Daegu, South Korea
[3] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea
[4] Seoul St Marys Hosp, Seoul, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea
[6] Ulsan Univ Hosp, Ulsan, South Korea
[7] Seoul Natl Univ, Coll Med, Seoul, South Korea
[8] Inje Univ, Coll Med, Haeundae Paik Hosp, Busan, South Korea
[9] Keimyung Univ, Dept Hematooncol, Dongsan Med Ctr, Daegu, South Korea
[10] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
[11] Gachon Univ, Gil Med Ctr, Seongnam, South Korea
[12] Daegu Catholic Univ Hosp, Daegu, South Korea
[13] Chung Ang Univ Hosp, Seoul, South Korea
[14] Natl Canc Ctr, Goyang, South Korea
[15] Natl Canc Ctr Korea, Dept Internal Med, Goyang, South Korea
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-144
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [41] High-dose melphalan with BCNU and etoposide as preparative regimen for autologous hemopoietic stem cell transplantation in multiple myeloma (MM)
    Bernasconi, P
    Alessandrino, EP
    Colombo, AA
    Caldera, D
    Bonfichi, M
    Martinelli, G
    Malcovati, L
    Varettoni, M
    Maiocchi, M
    Brusamolino, E
    Pagnucco, G
    Castagnola, C
    Corso, A
    Bernasconi, C
    BONE MARROW TRANSPLANTATION, 1999, 23 : S133 - S133
  • [42] High-dose melphalan on day 2 versus 1 before autologous stem cell transplantation for multiple myeloma
    Rakszawski, K.
    Drabick, J. J.
    Dolloff, N. G.
    Sivik, J. M.
    Malysz, J.
    Claxton, D.
    Ehmann, W. C.
    Rybka, W. B.
    Talamo, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Busulfan / Melphalan / Bortezomib (Bu-Mel-Vet) Vs. High Dose Melphalan As Conditioning Regimen For Autologous Hematopoietic Cell Transplantation In Multiple Myeloma (MM)
    Rodriguez, Tulio E.
    Hari, Parameswaran
    Stiff, Patrick J.
    Zhong, Xiaobo
    Sterrenberg, Danielle
    Vesole, David H.
    BLOOD, 2013, 122 (21)
  • [44] Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
    C Pasqualini
    C Dufour
    G Goma
    M-A Raquin
    V Lapierre
    D Valteau-Couanet
    Bone Marrow Transplantation, 2016, 51 : 227 - 231
  • [45] BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Veeraputhiran, Muthu
    Jain, Tania
    Deol, Abhinav
    Ayash, Lois
    Kim, Seongho
    Dyson, Gregory
    Bhutani, Divaya
    Lum, Lawrence G.
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    Abidi, Muneer H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (09): : 531 - 535
  • [46] BUSULFAN AND CYCLOPHOSPHAMIDE HAS SIMILAR OUTCOMES TO HIGH DOSE MELPHALAN AS A PREPARATIVE REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Mahindra, A.
    Bolwell, B.
    Rybicki, L.
    Dean, R.
    Poblman, B.
    Sobecks, R.
    Andresen, S.
    Sweetenbam, J.
    Kalaycio, M.
    Copelan, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 69 - 69
  • [47] Nonmyeloablative conditioning and allogeneic stem cell transplantation as consolidation therapy after high-dose melphalan and autologous stem cell transplantation for multiple myeloma
    Schneider, P
    Fenk, R
    Bernhard, A
    Huenerlituerkoglu, AN
    Aivado, M
    Wehmeier, A
    Pape, H
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S101 - S101
  • [48] High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study
    Musso, Maurizio
    Messina, Giuseppe
    Marcacci, Gianpaolo
    Crescimanno, Alessandra
    Console, Giuseppe
    Donnarumma, Daniela
    Scalone, Renato
    Pinto, Antonio
    Martino, Massimo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (11) : 1932 - 1938
  • [49] BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN FOR AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    ALEGRE, A
    LAMANA, M
    ARRANZ, R
    FERNANDEZVILLALTA, MJ
    TOMAS, JF
    FIGUERA, A
    CAMARA, R
    STEEGMAN, JL
    CASADO, F
    REQUENA, MJ
    PLANAS, JL
    VAZQUEZ, L
    GRANDA, A
    FERNANDEZRANADA, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 380 - 386
  • [50] The effectiveness of the conditioning regimen high dose melphalan with bortezomib with autologous transplantation of hematopoietic stem cells in patients with multiple myeloma
    Khorobrykh, Marina
    Zorina, Natalia
    Minaeva, Natalia
    Sherstnev, Philipp
    Paramonov, Igor
    BONE MARROW TRANSPLANTATION, 2018, 53 : 293 - 294
12345